“Burioni didn’t guess one”: this is the phrase with implicit yet very clear intentions that the virologist launched on from thrombosis characterized by blood clots and low blood platelet levels. The Anglo-Swedish pharmaceutical group admitted this for the first time, as part of a class action lawsuit in the United Kingdom. The news, spread by the Telegraph, was spread across the British media. “The causal mechanism” by which the vaccine can cause TTS “is not known,” the company said in legal documents filed in February. “TTS – he pointed out – can occur even in the absence of administration of the vaccine. The causal link in each individual case will be the subject of tests by experts”, added the company.
Read also: What’s the weather like, avian flu in milk? Burioni: “There is a very serious problem”
“According to the latest data from the United Kingdom, the incidence of thrombosis after the first dose of the AstraZeneca anti-Covid vaccine appears to be approximately one case per 75,000 vaccinated people. However, these are aggregate data which are of little use. Since the incidence of this serious side effect is very different by gender and age, it is essential to have disaggregated data”, wrote Roberto Burioni three years ago. “We hope that they will arrive soon, and that in this sense the vaccine manufacturer, which until now has been very silent and not very active, can also be activated”, we read in the article reposted by the immunologist on his social profile.
